Literature DB >> 4134293

Charcoal haemoperfusion in the treatment of fulminant hepatic failure.

B G Gazzard, M J Weston, I M Murray-Lyon, H Flax, C O Record, R Williams, B Portmann, P G Langley, E H Dunlop, P J Mellon, M B Ward.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4134293     DOI: 10.1016/s0140-6736(74)90678-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  40 in total

Review 1.  Extracorporeal perfusion for the treatment of acute liver failure.

Authors:  H B Stockmann; C A Hiemstra; R L Marquet; J N IJzermans
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

Review 2.  Cell therapies for liver diseases.

Authors:  Yue Yu; James E Fisher; Joseph B Lillegard; Brian Rodysill; Bruce Amiot; Scott L Nyberg
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

Review 3.  Artificial and bioartificial support systems for liver failure.

Authors:  J P Liu; L L Gluud; B Als-Nielsen; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2004

4.  Artificial liver support in fulminant hepatic failure.

Authors:  R Williams
Journal:  Bull N Y Acad Med       Date:  1975-04

5.  Plasma prostaglandins in fulminant hepatic failure.

Authors:  P Trewby; A Bennett; I M Murray-Lyon; R Williams
Journal:  Br Med J       Date:  1975-11-22

6.  Use of dialysis in the treatment of renal failure in liver disease.

Authors:  V Parsons; S P Wilkinson; M J Weston
Journal:  Postgrad Med J       Date:  1975-08       Impact factor: 2.401

7.  Artificial and bioartificial liver support.

Authors:  Gesine Pless
Journal:  Organogenesis       Date:  2007-01       Impact factor: 2.500

Review 8.  Acute liver failure.

Authors:  R D Hughes; J Wendon; A E Gimson
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

9.  Toxicokinetics of labeled amatoxins in the dog.

Authors:  H Faulstich; A Talas; H H Wellhöner
Journal:  Arch Toxicol       Date:  1985-01       Impact factor: 5.153

10.  Probable progress in the therapy of organophosphate poisoning: extracorporeal hemodialysis and hemoperfusion.

Authors:  S Okonek
Journal:  Arch Toxicol       Date:  1976-06-08       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.